Prenetics Global (PRE) Liabilities from Discontinued Operations (2024 - 2025)
Prenetics Global's (PRE) quarterly Liabilities from Discontinued Operations came in at $8.3 million in Q3 2025, down 65.63% quarter-over-quarter from $24.2 million in Q2 2025.
Powered by 
Analysis
Prenetics Global (PRE) Liabilities from Discontinued Operations (2024 - 2025) Analysis & Trends
Prenetics Global (PRE) has reported Liabilities from Discontinued Operations for 2 consecutive years, with $8.3 million the latest figure, recorded in Q3 2025.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to $8.3 million in Q3 2025; TTM through Sep 2025 was $8.3 million, a N/A change from a year earlier, with the FY2024 full-year figure at $25.4 million, changed N/A from the prior year.
- Liabilities from Discontinued Operations was $8.3 million for Q3 2025 at Prenetics Global, down from $24.2 million in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at $25.4 million in Q4 2024 and troughed at $8.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 8.33 Mn |
| Jun 30, 2025 | 24.25 Mn |
| Mar 31, 2025 | 23.87 Mn |
| Dec 31, 2024 | 25.37 Mn |